News

Experimental combination therapy trial for breast cancer patients no longer responding to treatment - 3578.png

This is how to beat the tumour cells that survive cancer therapy

16 June 2026
Vandetanib nearly doubles progression free survival for most common type of thyroid cancer - 3309.jpg

Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy

16 June 2026
La Jolla CAR T

Researchers identify target with potential to improve CAR T-cell therapy response in patients with blood cancers

16 June 2026
Is there a role for 'modified VAD' in the treatment of multiple myeloma? - resized_bm.jpeg

New treatment combination delays multiple myeloma progression and may improve survival, study finds

16 June 2026
generic brain

Immune activation may determine success of dual-target CAR T therapy in glioblastoma

16 June 2026
leukaemia

Novel combination therapy reduces leukaemia relapse rate, extending window for bone marrow transplants

12 June 2026
Cardiac risk factors in prostate cancer treatment

Research suggests early heart changes may predict future cancer risk

12 June 2026
bio dna

Developing DNA-based nanostructures for targeted cancer therapy

12 June 2026
Epidemiology of human papillomavirus related cancers in India

People with traumatic brain injury more likely to die from brain cancer than general population

12 June 2026
Advanced pancreatic tumors depend on continued oncogene activity - 2771.png

Stopping cancer proteins before they even form?

12 June 2026
blood

Scientists develop nanoparticle delivery system to target blood cancer cells

11 June 2026
A link in a protein between ALS and cancer  - 3559.png

Mapping cancer’s hidden protein control system

11 June 2026
Back to Top